![]() We’re very optimistic about the future,” said Atria. “Obviously, it’s a great moment for us right now since we just closed a seed fund. With this latest round of seed funding in hand, nView medical is poised to further accelerate the commercialization of the technology and expand the company. ![]() That way we increase our chances to get funded,” said Atria, who noted that working with the USTAR SBIR Center significantly increases a company’s chance at winning SBIR funding. They review our application and give us feedback. “Every grant application that we do we always work with USTAR. The company received Phase I and II SBIR grants from the National Science Foundation, and the National Institutes of Health, with assistance from the USTAR SBIR Center. The company received a USTAR Technology Acceleration Program (TAP) grant and is a client of the USTAR SBIR Center. NView medical has worked closely with USTAR since the company was founded in 2013. Programs like USTAR or federal funding work because they are de-risking investments.” “State funding really helps us because we’re not ready for venture capital early on. It’s very science based, so it takes a while for technologies like ours to be ready for commercialization,” said Atria. “If you take a look at a company like ours, we’re really based on deep technology. “It’s allowing us to hire management and also engineers that will help us refine the product,” said Atria.Ĭristian Atria, founder and CEO of nView medicalĪs nView medical celebrates a successful funding round, Atria emphasized that state support through USTAR and other government programs was essential for making the company attractive to private sector investors. According to Atria, the company plans to hire four more full-time employees in the coming months. With this recent round of seed funding, the company can begin the necessary regulatory clearances to bring the product to market, and hire new staff. Through artificial intelligence, model based imaging, and machine learning, nView’s imaging system increases accuracy and shortens surgical times. NView’s technology decreases the likelihood of repeat surgeries by providing real-time 3D visualization during surgery. There are over 30,000 spinal implant revision surgeries within 30 days of the first operation in the United States, costing more than $1 billion each year. The company is developing a real-time 3D imaging system that will make common surgical procedures faster and more accurate. “And that’s a necessary step for us to commercialize our product.” “This funding will allow us to go through regulatory clearances,” said Cristian Atria, founder and CEO of nView medical. The company has been supported by the Utah Science Technology and Research Initiative (USTAR) through a Technology Acceleration Program (TAP) grant and the USTAR SBIR Center. The funding round was led by Fusion Fund with the participation of angel investors and matching funds from the National Science Foundation and the State of Utah. NView medical, a Utah surgical imaging company, recently raised $1.2 million in seed financing.
0 Comments
Leave a Reply. |